White blood cell count abnormalities and infections in one-year follow-up of 124 patients with SLE

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 103-107

  Dias, Ana Margarida Brito ^a   Do Couto, Maura Cristina Medeiros ^a,b   Duarte, Cátia Cristina Marques ^a   Inês, Luís Pedro Bolotinha ^a,c   Malcata, Armando Boavida ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Infection; Leukopenia; Lymphopenia; Neutropenia; Systemic lupus erythematosus; Vaccination; White blood cell

Indexed keywords

ADULT; CLINICAL EVALUATION; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; INFECTION; INFECTION RISK; LEUKOCYTE COUNT; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; PERICARDITIS; PNEUMONIA; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPPER RESPIRATORY TRACT INFECTION; UROGENITAL TRACT INFECTION; VACCINATION;

EID: 69949162408     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04872.x     Document Type: Conference Paper

References (33)

1. Tan, E.M. et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
2. Quismorio Jr, F.P. 2007. Hematologic and lym-phoid abnormalities in systemic lupus erythemato-sus. Dubois' lupus erythematosus. 7th edn, Lippin-cott Williams & Wilkins, Baltimore, pp. 801-828.
3. Ward, M.M. et al. 1995. Long term survival in systemic lupus erythematosus: patient characteristics associated with poorer outcomes. Arthritis Rheum. 38: 274-283.
4. Cervera, R. et al. 1999. Morbidity and mortality in systemic lupus erythematosus during 5-year period. A multicenter prospective study of 1, 000 patients. European Working Party on Systemic Lupus Erythematosus; Medicine. 78: 167-175.
5. Nived, O. et al. 1985. Systemic lupus erythematosus and infection: a controlled study including an epi-demiological group. Q. J. Med. 55: 271-278.
6. Petri, M. et al. 1992. Incidence and risk factors for hospitalization in systemic lupus erythematosus. J. Rheumatol. 19: 1559-1565.
7. Ginzler, E. et al. 1978. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 21: 37-44.
8. Duffy, K.N. et al. 1991. Infection and disease activity in systemic lupus erytematosus: a review of hospitalized patients. J. Rheumatol. 18: 1180-1184.
9. Zonana-Nacach, A. et al. 2001. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10: 505-510.
10. Gladman, D. et al. 2002. The nature and outcome of infection in systemic lupus erythematosus. Lupus 11: 234-239. (Pubitemid 34506728)
11. Mills, J.A. 1994. Systemic lupus erythematosus. New Eng. J. Med. 330: 1871-1879.
12. Al-Rayes, H. et al. 2007. Systemic lupus erythemato-sus and infections: a retrospective study in Saudis. Lupus 16: 755-763.
13. Hellmann, D.B. et al. 1987. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 66: 341-348.
14. Doria A. et al. 2006. Long-term prognosis and causes of death in systemic lupus erythematosus. Am. J. Med. 119: 700-706.
15. Petri, M. 1998. Infections in systemic lupus erythe-matosus. Rheum. Dis. Clin. North Am. 24: 423-456.
16. Zonana-Nacach, A. et al. 2001. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10: 505-10.
17. Noël, V. 2001. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann. Rheum. Dis. 60: 1141-1144.
18. Michael, H. 1999. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus. Arthritis Rheum. 42: 2023-2025.
19. Lee, P.W. 2007. Recurrent major infections in juvenile-onset systemic lupus erythematosus-a close link with long-term disease damage. Rheumatology (Oxford) 46: 1290-1296. Epub 2007 May 23.
20. Hidalgo-Tenorio, C. 2004. Urinary tract infections and lupus erythematosus. Ann. Rheum. Dis. 63: 431-437.
21. Bosch, X. et al. 2006. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15: 584-589.
22. Centers for Disease Control and Prevention, www.cdc.gov/vaccines.
23. Frick, S. et al. 2001. Necrotizing fasciitis due to Streptococcus pneumonia after intramuscular injection of non-steroidal anti-inflammatory drugs. Clin. Infect. Dis. 33: 740-744.
24. Elkaiam, O. et al. 2005. Pneumococcal vaccination of patients with systemic lupus erythematosus: Effects on generation of autoantibodies. Autoimmunity 38: 493-496.
25. Michael, H.V. 1999. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus. Arthritis Rheum. 42: 2023-2025.
26. Katsanis, E.et al. 1987. Systemic lupus erythematosus and sickle hemoglobinopathies: a report of two cases and review of the literature. Am. J. Hematol. 25: 211-214.
27. Dubois, E.L. et al. 1964. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190: 104-111.
28. Estes, D. et al. 1971. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971: 85-95.
29. Ng, W.L. et al. 2006. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 99: 37-47.
30. Ling-Ying, L. 2007. Infections: inseparable from lupus? J. Rheumatol. R.O.C. 21: 1-3.
31. Kinder, W. et al. 2007. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum. 56: 2679-2686.
32. Jallouli, M.et al. 2008. Infectious complications in systemic lupus erythematosus: A series of 146 patients. Rev. Med. Intern. 29: 626-631.
33. Conti F. et al. 2008. Vaccination and autoimmune rheumatic diseases. Autoimmun. Rev. 8: 124-128.